| Bioactivity | Farglitazar is a PPARγ agonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients. |
| Name | Farglitazar |
| CAS | 196808-45-4 |
| Formula | C34H30N2O5 |
| Molar Mass | 546.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen L, Yang B, McNulty JA, et al. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther. 2005;312(2):718-725. |
Farglitazar
CAS: 196808-45-4 F: C34H30N2O5 W: 546.61
Farglitazar is aPPARγ agonistthat has significant therapeutic benefits such as glycemic control in type 2 diabetic pati
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.